The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line chemotherapy versus chemoradiation for resectable distal esophageal adenocarcinoma.
 
Susanna W. L. de Geus
No Relationships to Disclose
 
Sameer Hirji
No Relationships to Disclose
 
Sing Chau Ng
No Relationships to Disclose
 
Teviah E. Sachs
No Relationships to Disclose
 
Jennifer F. Tseng
Consulting or Advisory Role - Aegerion (I); Aegerion (I); Aegerion (I); Aegerion (I); Amgen (I); Amgen (I); Amgen (I); Amgen (I); AstraZeneca (I); AstraZeneca (I); AstraZeneca (I); AstraZeneca (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Cubist (I); Cubist (I); Cubist (I); Cubist (I); Daiichi Sankyo/Lilly (I); Daiichi Sankyo/Lilly (I); Daiichi Sankyo/Lilly (I); Daiichi Sankyo/Lilly (I); GlaxoSmithKline (I); GlaxoSmithKline (I); GlaxoSmithKline (I); GlaxoSmithKline (I); Intarcia Therapeutics (I); Intarcia Therapeutics (I); Intarcia Therapeutics (I); Intarcia Therapeutics (I); Merck (I); Merck (I); Merck (I); Merck (I); MyoKardia (I); MyoKardia (I); MyoKardia (I); MyoKardia (I); Pfizer (I); Pfizer (I); Pfizer (I); Pfizer (I); Quest Diagnostics (I); Quest Diagnostics (I); Quest Diagnostics (I); Quest Diagnostics (I); Sanofi (I); Sanofi (I); Sanofi (I); Sanofi (I); Vertex (I); Vertex (I); Vertex (I); Vertex (I); Zeus Oncology Fund (I); Zeus Oncology Fund (I); Zeus Oncology Fund (I); Zeus Oncology Fund (I)